Total Funding
71
66
Total FundingSeries A raised
Growth Score
-6 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
14832
AltrixBio is a pharmaceutical company focused on oral drug that replicates the metabolic success of bariatric surgery.
- Ali Tavakkoli: Co-Founder & Chief Clinical AdvisorPast Role: Brigham and Women's Hospital, Chief of Division of General and GI Surgery
- David Pass: President and Chief Executive OfficerPast Role: Glooko, President of Life Sciences
About the Company
AltrixBio is a developer of therapeutic drugs designed for controlled gastrointestinal targeting. They treat patients by providing duodenal isolation similar to gastric bypass, enabling patients with an oral drug that replicates the metabolic success of bariatric surgery and is quite financially feasible than surgery.
Women Founded
Women Led
